MAXIPHARMA A/S: Financial statements 2013
CVR: 87375617
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 972,850 and a net result of DKK -221,543 compared with DKK 740,393 the year before. That is a decrease of 35.9% compared with the year before. Equity in the 2013 report amounted to DKK 2,076,935. The solvency ratio was 64.4%.
- Gross Profit
- DKK 972,850
- Profit/Loss
- DKK -221,543
- Equity
- DKK 2,076,935
- Total Assets
- DKK 3,223,688
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 973 t. | -222 t. | 2.1 mio. | - |
| 2012 | - | 1.5 mio. | 740 t. | 2.3 mio. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
MAXIPHARMA A/S has published its annual report for 2012. Gross profit came to DKK 1,517,078, and the net result was DKK 740,393.
As of January 1, 2013, MJAKP P/S has been appointed auditor of MAXIPHARMA A/S.
About MAXIPHARMA A/S
MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The board consists of Benedikte Mailand Jensen (chair), Henrik Bencke and Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.